Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > News out !

<< Previous

Bullboard Posts

Next >>

Comment by Oilminerdeluxeon Aug 28, 2024 7:31am

126 Views

Post# 36198948

RE:News out !

I like it when the first post reply is OMG!!! ... That sort of bodes well for what you will read next.

"Theralase® believes that this preclinical data could be even further improved with the addition of radiation or Metformin to activate Rutherrin®, while resident in NSCLC cells."

"These results also suggest an exciting new direction for Theralase® in future drug development to help overcome chemoresistance, which is one of the major clinical challenges in cancer therapy".

So will people sell off more to participate in the pp today?